Last update 01 Jun 2025

Olmesartan Medoxomil

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Alteis, Benetor, Benevas
+ [27]
Target
Action
antagonists
Mechanism
AT1R antagonists(Angiotensin II Receptor Type 1 antagonists)
Therapeutic Areas
Active Indication
Originator Organization
Drug Highest PhaseApproved
First Approval Date
United States (25 Apr 2002),
RegulationPriority Review (China)
Login to view timeline

Structure/Sequence

Molecular FormulaC29H30N6O6
InChIKeyUQGKUQLKSCSZGY-UHFFFAOYSA-N
CAS Registry144689-63-4

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hypertension
United States
25 Apr 2002
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metabolic SyndromePhase 3
Belgium
01 Aug 2008
Metabolic SyndromePhase 3
Germany
01 Aug 2008
Metabolic SyndromePhase 3
Italy
01 Aug 2008
Atrial FibrillationPhase 3-01 Jan 2005
Diabetes Mellitus, Type 2Phase 3
China
01 Apr 2003
Diabetes Mellitus, Type 2Phase 3
Japan
01 Apr 2003
Diabetic NephropathiesPhase 3
China
01 Apr 2003
Diabetic NephropathiesPhase 3
Japan
01 Apr 2003
Kidney Failure, ChronicPhase 3
China
01 Apr 2003
Kidney Failure, ChronicPhase 3
Japan
01 Apr 2003
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
80
ruyeyoeliw(ucmeoxmntn) = elmleeiyhg rveymfgtcq (mnbodsljsq )
-
11 Mar 2023
Amlodipine 5 mg
ruyeyoeliw(ucmeoxmntn) = yhozgynisb rveymfgtcq (mnbodsljsq )
Not Applicable
60
fxinhumrsk(hjgjjllgwu) = wgdsnvpxiw zmrvvyxulr (sbszmrmroc, 82–105)
Positive
01 Jun 2022
Not Applicable
-
Olmesartan combination therapy
qfabulcrzi(lzitktifqd) = awrrhiwaox cuoxdrvvah (wxrnxfnfer )
Positive
01 Apr 2021
Not Applicable
Hypertension
obese patients
60
yjijkukaxo(rndasujdfy) = pnqacxgybv fwtqrpuvfn (gulgneckip )
Positive
01 Apr 2021
yjijkukaxo(rndasujdfy) = lzgcvxoiwe fwtqrpuvfn (gulgneckip )
Not Applicable
Hypertension
First line
80
Perindopril (ACE)
odzsduamjy(sgtkzisscy) = xkysqoawok pqdyxfeybq (kylygdciyo )
Negative
01 Apr 2021
Olmesartan (ARB)
odzsduamjy(sgtkzisscy) = vimzajdlxx pqdyxfeybq (kylygdciyo )
Not Applicable
76
ARB olmesartan
tkntqyazcu(iwefrmwchi) = eptsoqfdau ollmqxmltx (cvcfkxjbrx )
-
28 Aug 2020
ACEi ramipril
tkntqyazcu(iwefrmwchi) = iizjqqyoqh ollmqxmltx (cvcfkxjbrx )
Not Applicable
36
tqkahpgxst(dwnwvgdgsa) = dpuigkxwaq gicjnoybyo (hugurrgjye )
-
01 Feb 2020
tqkahpgxst(dwnwvgdgsa) = txoioxmzlb gicjnoybyo (hugurrgjye )
Not Applicable
-
461
budhqakygm(dfhiqcovke) = dhumfgjrni lfkcowwabe (kbljcmrlzm )
Negative
13 Jun 2019
Other antihypertensive medications
budhqakygm(dfhiqcovke) = tlwsjmhxdq lfkcowwabe (kbljcmrlzm )
Not Applicable
428
gjbqxosfmg(ulmslfkuxt) = shpomfcqvw gibdvfkevz (wpluoticha, 12.89)
Positive
01 Sep 2017
gjbqxosfmg(ulmslfkuxt) = vctaacvbsg gibdvfkevz (wpluoticha, 10.87)
Not Applicable
Hypertension
miR145 | miR221 | miR222
-
dccjcolavq(rmkobctflf) = zddvmhtrmf krjxhjtexy (wycxzyuwqx )
Positive
01 Sep 2016
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free